Astria Therapeutics, Inc.
News
ATXS Makes Notable Cross Below Critical Moving Average
Market News Video In trading on Thursday, shares of Astria Therapeutics Inc (ATXS) crossed below their 200 day moving average of 10.41, changing hands as low as 10.28 per share. Astria Therapeutics Inc...\n more…
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 180,000...\n more…
Astria Therapeutics to Present at Upcoming Bradykinin Symposium
Business Wire Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present two...\n more…
Astria Therapeutics to Participate in Upcoming Morgan Stanley 22nd Annual Global Healthcare Conference
Business Wire Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will participate in...\n more…
Astria Therapeutics, Inc. (NASDAQ:ATXS) Receives $25.20 Consensus PT from Analysts
Ticker Report Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS - Get Free Report) have been assigned a consensus recommendation of "Buy" from the six ratings firms that are currently covering the company...\n more…